/주식/GMAB
GMAB

GMAB

USD

Genmab A/S ADS

$28.975+0.435 (1.524%)

실시간 가격

Healthcare
생명공학
덴마크

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$28.540

고가

$29.390

저가

$28.510

거래량

2.92M

기업 기본 정보

시가총액

17.8B

산업

생명공학

국가

Denmark

거래 통계

평균 거래량

2.00M

거래소

NMS

통화

USD

52주 범위

저가 $17.235현재가 $28.975고가 $33.65

관련 뉴스

BusinessWire

Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting

More than 20 abstracts, including seven oral presentations, highlight advancements from the epcoritamab development program supporting the expanded clinical profile and potential of epcoritamab for a broader range of

더 보기
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $40 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Genmab with a Buy and maintains $40 price target.

더 보기
HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $40 Price Target
GlobeNewswire

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025

Company Announcement Net sales of DARZALEX® in the third quarter of 2025 totaled USD 3,672 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech,

더 보기
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025